0001562180-18-003073.txt : 20180621 0001562180-18-003073.hdr.sgml : 20180621 20180621160700 ACCESSION NUMBER: 0001562180-18-003073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180619 FILED AS OF DATE: 20180621 DATE AS OF CHANGE: 20180621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Calcaterra Chris M. CENTRAL INDEX KEY: 0001640771 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37463 FILM NUMBER: 18911922 MAIL ADDRESS: STREET 1: C/O GLAUKOS CORPORATION STREET 2: 26051 MERIT CIRCLE, SUITE 103 CITY: LAGUNA HILLS STATE: CA ZIP: 92653 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLAUKOS Corp CENTRAL INDEX KEY: 0001192448 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 229 AVENIDA FABRICANTE CITY: SAN CLEMENTE STATE: CA ZIP: 92672 BUSINESS PHONE: 949-367-9600 MAIL ADDRESS: STREET 1: 229 AVENIDA FABRICANTE CITY: SAN CLEMENTE STATE: CA ZIP: 92672 FORMER COMPANY: FORMER CONFORMED NAME: GLAUKOS CORP DATE OF NAME CHANGE: 20020925 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-06-19 false 0001192448 GLAUKOS Corp GKOS 0001640771 Calcaterra Chris M. C/O GLAUKOS CORPORATION 229 AVENIDA FABRICANTE SAN CLEMENTE CA 92672 false true false false Chief Operating Officer Common Stock 2018-06-19 4 M false 7759.00 4.225 A 247759.00 D Common Stock 2018-06-19 4 S false 7759.00 44.01 D 240000.00 D Common Stock 2018-06-20 4 M false 1870.00 4.225 A 241870.00 D Common Stock 2018-06-20 4 M false 600.00 16.49 A 242470.00 D Common Stock 2018-06-20 4 S false 2470.00 44.03 D 240000.00 D Stock Options (Right to buy) 4.225 2018-06-19 4 M false 7759.00 0.00 D 2023-01-29 Common Stock 7759.00 1870.00 D Stock Option (Right to buy) 4.225 2018-06-20 4 M false 1870.00 0.00 D 2023-01-29 Common Stock 1870.00 0.00 D Stock Options (Right to buy) 16.49 2018-06-20 4 M false 600.00 0.00 D 2026-03-10 Common Stock 600.00 99400.00 D These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. This transaction was executed in multiple trades at prices ranging from $44.00 to $44.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $44.00 to $44.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option was granted on January 29, 2013, and had a four-year vesting schedule in which 25% vested on the first year anniversary date of the grant and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. This option was granted on March 10, 2016, and has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests in equal monthly installments for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. /s/ Robert Davis, Attorney-in-Fact 2018-06-21